Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-16-012633

Director bought 15,000 shares at an average $1.99 ($29,900)

From the SEC's structured data for this filing

Trades in this filing

SETH SANDESH · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2016-04-14 Purchase : show line 1 in the form +5,000 $2.00 $10,000 15,000 D
2016-04-15 Purchase : show line 2 in the form +2,000 $2.00 $4,000 17,000 D
2016-04-15 Purchase : show line 3 in the form +1,500 $2.01 $3,015 18,500 D
2016-04-18 Purchase : show line 4 in the form +5,000 $1.98 $9,900 23,500 D
2016-04-18 Purchase : show line 5 in the form +1,500 $1.99 $2,985 25,000 D
Open-market purchases · 15,000 sh · avg $1.99 · $29,900

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-04-15 Grant or award : show line 6 in the form Options to purchase common stock +500,000 $1.99 $995,000 500,000 D
Loading xslF345X03/f4041416seth_actiniumpharm.xml…